Filing Details
- Accession Number:
- 0001731122-22-001013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-27 20:30:22
- Reporting Period:
- 2022-05-25
- Accepted Time:
- 2022-05-27 20:30:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1314052 | Anavex Life Sciences Corp. | AVXL | Biological Products, (No Disgnostic Substances) (2836) | 208365999 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1360570 | Athanasios Skarpelos | 630 5Th Avenue 20Th Floor New York NY 10111 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-25 | 50,000 | $0.92 | 1,356,458 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-05-25 | 50,000 | $9.06 | 1,306,458 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2022-05-25 | 50,000 | $0.00 | 50,000 | $0.92 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-04-02 | No | 4 | M | Direct |
Footnotes
- The options subject to this grant vested quarterly over a three-year period commencing on April 2, 2015.